GlassScriptPhysician profile
Thomas J Spillane
NPI 1477558435
$59,907.89
in general payments reported to CMS, 2019-2025
97 companies · $7,854 in 2025
The $7,854 reported for 2025 was more than what 78% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,268 · 2020: $9,656 · 2021: $14K · 2022: $11K · 2023: $4,914 · 2024: $7,697 · 2025: $7,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Consulting Fee: $3,375 · Long Term Medical Supply Or Device Loan: $167 · Education: $49.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,873.58 |
| Consulting Fee | $3,375.00 |
| Long Term Medical Supply Or Device Loan | $166.66 |
| Education | $49.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13,260.06 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $9,105.17 | 2019-2025 | Calquence, Lynparza, Enhertu |
| Novartis Pharmaceuticals Corporation | $2,858.71 | 2019-2025 | |
| Janssen Biotech, INC. | $2,059.22 | 2019-2025 | Carvykti, Tecvayli, Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $1,829.27 | 2019-2025 | Opdivo, Opdualag |
| Karyopharm Therapeutics INC. | $1,743.25 | 2021-2025 | Xpovio |
| Merck Sharp & Dohme LLC | $1,686.19 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Janssen Scientific Affairs, LLC | $1,639.99 | 2022-2023 | Tecvayli |
| Daiichi Sankyo INC. | $1,563.54 | 2019-2025 | Enhertu, Vanflyta, Injectafer |
| Astellas Pharma US INC | $1,379.43 | 2019-2025 | Padcev, Xospata, Xtandi |
| Exelixis INC. | $1,377.74 | 2019-2025 | Cabometyx |
| Amgen INC. | $1,301.40 | 2019-2025 | Evenity, Lumakras, Blincyto |
| Genentech USA, INC. | $1,278.72 | 2019-2025 | Venclexta, Lunsumio, Columvi |
| Seagen INC. | $1,190.68 | 2019-2023 | Adcetris, Padcev, Tukysa |
| Pfizer INC. | $1,081.75 | 2019-2025 |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $897.47 | 2019-2025 | Ojjaara, Zejula, Jemperli |
| Celgene Corporation | $860.81 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Eisai INC. | $821.93 | 2019-2025 | |
| Blueprint Medicines Corporation | $784.71 | 2020-2025 | Ayvakit |
| Emd Serono, INC. | $783.99 | 2019-2025 | |
| Genzyme Corporation | $781.45 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $749.22 | 2019-2025 | Iclusig, Alunbrig, Fruzaqla |
| Abbvie INC. | $719.89 | 2019-2025 | |
| Lilly USA, LLC | $615.43 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Beigene, LTD. | $525.00 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $475.70 | 2019-2023 | Imbruvica, Epkinly |
| Adc Therapeutics America, INC. | $473.47 | 2021-2025 | |
| Incyte Corporation | $462.37 | 2019-2025 | Monjuvi, Jakafi |
| Puma Biotechnology, INC. | $455.30 | 2019-2025 | |
| Sobi, INC | $449.60 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $435.94 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Alexion Pharmaceuticals, INC. | $396.78 | 2019-2025 | Ultomiris |
| Array Biopharma INC | $379.68 | 2019-2025 | Braftovi, Lorbrena, Mektovi |
| Pharmaessentia USA Corporation | $285.43 | 2022-2025 | Besremi |
| Jazz Pharmaceuticals INC. | $263.95 | 2021-2025 | |
| Stemline Therapeutics INC. | $248.42 | 2023-2025 | Orserdu, Elzonris |
| Gilead Sciences, INC. | $238.51 | 2021-2025 | Trodelvy |
| Clovis Oncology, INC. | $228.22 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $218.37 | 2019-2025 | Libtayo |
| Beigene USA, INC. | $215.11 | 2021-2025 | Brukinsa, Tevimbra |
| Kite Pharma, INC. | $206.81 | 2021-2023 | |
| Alnylam Pharmaceuticals INC. | $201.46 | 2024-2025 | Givlaari, Onpattro |
| Genmab U.S., INC. | $198.80 | 2024-2025 | Epkinly |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.33 | 2019-2025 | Gilotrif |
| Amag Pharmaceuticals, INC. | $175.82 | 2019-2022 | |
| Secura Bio, INC. | $172.29 | 2021-2025 | Copiktra |
| Dendreon Pharmaceuticals LLC | $171.29 | 2019-2023 | Provenge |
| Morphosys, US INC. | $170.35 | 2021-2024 | Monjuvi |
| Aveo Pharmaceuticals, INC. | $150.83 | 2022-2025 | Fotivda |
| Beone Medicines USA, INC. | $144.64 | 2025 | Brukinsa, Tevimbra |
| Mirati Therapeutics, INC. | $120.43 | 2023-2024 | Krazati |
| Ipsen Biopharmaceuticals, INC | $114.55 | 2022-2024 | Onivyde, Tazverik, Somatuline Depot |
| Myovant Sciences INC. | $102.16 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $98.16 | 2022-2024 | Empaveli |
| Syndax Pharmaceuticals, INC. | $94.80 | 2025 | |
| Tersera Therapeutics LLC | $86.99 | 2021-2025 | Zoladex |
| Coherus Oncology, INC. | $86.39 | 2022-2025 | Loqtorzi |
| Springworks Therapeutics, INC. | $84.50 | 2024-2025 | Ogsiveo |
| Agios Pharmaceuticals, INC. | $80.12 | 2019-2025 | Pyrukynd |
| Tolmar Pharmaceuticals, INC. | $78.15 | 2020-2021 | |
| Taiho Oncology, INC. | $76.39 | 2023-2025 | |
| Dova Pharmaceuticals | $65.09 | 2019-2020 | |
| Servier Pharmaceuticals LLC | $55.48 | 2024-2025 | |
| Recordati_rare_diseases_inc. | $54.80 | 2024-2025 | Sylvant, Enjaymo |
| Menarini Silicon Biosystems, INC. | $46.62 | 2025 | |
| Epizyme, INC. | $45.94 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $45.41 | 2024-2025 | Monoferric |
| Accord Healthcare, INC. | $43.51 | 2025 | |
| Deciphera Pharmaceuticals INC. | $42.91 | 2024 | Qinlock |
| Kyowa Kirin, INC. | $42.82 | 2022 | |
| Myriad Genetic Laboratories, INC. | $40.58 | 2022 | |
| Tesaro, INC. | $39.06 | 2019 | |
| Immunogen, INC. | $32.26 | 2023 | Elahere |
| Acrotech Biopharma INC. | $29.83 | 2021-2022 | |
| Medtronic, INC. | $29.30 | 2024 | Synchromedii |
| Heron Therapeutics, INC. | $26.93 | 2022 | |
| Caris Mpi, INC. | $26.44 | 2025 | Mi Cancer Seek |
| Helsinn Therapeutics (U.S.), INC. | $25.74 | 2019 | |
| Fresenius Kabi USA, LLC | $20.71 | 2024 | Stimufend |
| Azurity Pharmaceuticals, INC. | $19.69 | 2025 | Danziten |
| Sirtex Medical INC | $18.79 | 2023 | Sir-Spheres Microspheres |
| Cti Biopharma Corp. | $18.59 | 2022 | |
| Mylan Institutional INC. | $18.19 | 2020 | |
| Geron Corporation | $17.99 | 2025 | Rytelo |
| Verity Pharmaceuticals INC. | $17.16 | 2025 | Trelstar |
| Sanofi-Aventis U.S. LLC | $16.59 | 2019 | |
| Verastem, INC. | $16.49 | 2019 | |
| Fennec Pharmaceuticals, INC. | $15.65 | 2025 | Fyarro |
| Cumberland Pharmaceuticals, INC. | $15.58 | 2023 | Sancuso |
| Adaptive Biotechnologies Corporation | $15.32 | 2025 | Clonoseq |
| Nestle Healthcare Nutrition INC. | $14.69 | 2021 | |
| Foundation Medicine, INC. | $14.61 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.30 | 2022 | |
| Organon LLC | $13.78 | 2023 | Ontruzant |
| Sun Pharmaceutical Industries INC. | $12.91 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Calquence $1,877Stivarga $1,247Enhertu $937Cabometyx $841Lynparza $816Keytruda $654Tecvayli $582Carvykti $518Padcev $504Venclexta $457Rybrevant $411Imbruvica $382Epkinly $369Opdivo $358Darzalex $353Jaypirca $311Elrexfio $296Lenvima $296Reblozyl $276Besremi $266Tagrisso $252Kisqali $242Pluvicto $228Ojjaara $227Orserdu $223Lorbrena $211Brukinsa $207Braftovi $203Zynlonta $195Vonjo $195Adcetris $193Givlaari $186Xtandi $183Zejula $177Lunsumio $177Columvi $177Phesgo $171Doptelet $167Mektovi $163Xofigo $155Nubeqa $155Ayvakit $154Trodelvy $150Libtayo $144Iclusig $143Verzenio $141Xospata $128Xalkori $123Erleada $123Tivdak $122Scemblix $121Krazati $120Ultomiris $118Inlyta $117Jemperli $115Evenity $114Talvey $111Monjuvi $110Xpovio $109Tavalisse $108Rezlidhia $108Zepzelca $108Enjaymo $107Vanflyta $104Ibrance $103Vyloy $101Alunbrig $100Polivy $98.54Bosulif $98.04Fruzaqla $93.04Lutathera $91.28Tukysa $88.73Injectafer $87.85Tevimbra $86.38Empaveli $83.71Opdualag $83.07Cablivi $77.07Inqovi $76.39Lonsurf $76.39Copiktra $74.63Nerlynx $73.97Elahere $71.58Gavreto $68.63Fotivda $67.49Ogsiveo $67.37Mekinist $66.22Sarclisa $65.67Talzenna $65.50Pyrukynd $65.14Retevmo $61.19Welireg $55.43Pomalyst $55.16Onivyde $52.75Ziihera $52.49Tecentriq $49.85Lumakras $47.69Vitrakvi $47.46Cellsearch $46.62Imfinzi $46.32Monoferric $45.41
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Spillane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.